Rankings
▼
Calendar
AKBA FY 2015 Earnings — Akebia Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
AKBA
Akebia Therapeutics, Inc.
$366M
FY 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$96,000
Operating Income
-$62M
Net Income
-$61M
EPS (Diluted)
$-2.29
Cash Flow
Operating Cash Flow
-$52M
Free Cash Flow
-$53M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$143M
Total Liabilities
$12M
Stockholders' Equity
$131M
Cash & Equivalents
$50M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$96,000
-$23M
+99.6%
Operating Income
-$62M
-$38M
-62.1%
Net Income
-$61M
-$37M
-63.9%
← FY 2014
All Quarters
Q1 2016 →